Lepzacitinib is a selective, small molecule JAK1/3 inhibitor used for the treatment of atopic dermatitis and other skin diseases. As a Janus kinase inhibitor, it reduces the inflammatory response.
Molecular Weight:
355.39
Purity:
99.85%
CAS Number:
[2321488-47-3]
Formula:
C18H21N5O3
Target:
JAK
T78207
* VAT and and shipping costs not included. Errors and price changes excepted